Completed Access to Information Requests

Follow:

  • RSS
  • Cite
About this information

Search the summaries of completed Access to Information (ATI) requests to find information about ATI requests made to the Government of Canada after January 2020. If you find a summary of interest, you can request a copy of the records at no cost using the form below each summary. Requests made through this form are considered informal requests and are not subject to the same requirements as requests under the Access to Information Act (ATIA). For additional information, please see the “About Access to Information Requests” webpage.

If you don’t find what you are looking for you can request additional government records under an institution’s control by contacting the institution’s Access to Information and Privacy Coordinator or by submitting a formal access to information request.

*All information provided will incorporate the necessary exemptions and exclusions as per the Access to Information Act and the Privacy Act.

Download datasets of the summaries of completed access to information requests.

Current Search

Report Type

Organization

Disposition

Year

Month

Found 375 record(s)

Req # A-2022-001445

Adverse Drug Reaction (ADR). Report number: E2B_05792642.

Organization: Health Canada

15 page(s)
May 2023

Req # A-2022-001451

Briefing note in the Ministerial Executive Correspondence System (MECS) for the following file: 22-075406-962.

Organization: Health Canada

5 page(s)
May 2023

Req # A-2022-001453

Briefing note in the Ministerial Executive Correspondence System (MECS) for the following file: 22-111972-42.

Organization: Health Canada

7 page(s)
May 2023

Req # A-2022-001460

Adverse Drug Reactions (ADRs). Report numbers: 000987016, 000987017, 000987019, 000987020, E2B_05094781, E2B_05100054, E2B_05100069, E2B_05272772, 000987022, 000987025.

Organization: Health Canada

197 page(s)
May 2023

Req # A-2022-001463

Adverse Drug Reaction (ADR) for DOXYLAMINE SUCCINATE / PYRIDOXINE HYDROCHLORIDE. Report number: E2B_05933342.

Organization: Health Canada

38 page(s)
May 2023

Req # A-2022-001467

Adverse Drug Reactions (ADRs). Report numbers: E2B_05933105, 001016349, E2B_05917203, E2B_05925115, 001016201, E2B_05886658, E2B_05884649, 001016116, E2B_05949583, E2B_05955018.

Organization: Health Canada

300 page(s)
May 2023

Req # A-2022-001468

Adverse Drug Reactions (ADRs). Report numbers: 001017761, E2B_05934321, E2B_05923043, E2B_05916486, 001016253, E2B_05880850, E2B_05959630, E2B_05897976, 001017946 E2B_05881222.

Organization: Health Canada

470 page(s)
May 2023

Req # A-2022-001473

Adverse Drug Reactions (ADRs) for PATIROMER. Report numbers: E2B_05928753, E2B_05929411, E2B_05937963. ADRs for SUCROFERRIC OXYHYDROXIDE. Report numbers: E2B_05897175, E2B_06025390. ADR for REXULTI. Report number: E2B_05885061. ADR for REXULTI AND ARIPIPRAZOLE. Report number: E2B_05889613. ADRs for ABILIFY. Report numbers: 001015815, E2B_05901585.

Organization: Health Canada

105 page(s)
May 2023

Req # A-2022-001474

Adverse Drug Reactions (ADRs) for ABILIFY MAINTENA. Report numbers: 001016212, E2B_05937468, E2B_05969422. ADRs for ABILIFY MAINTENA AND ARIPIPRAZOLE. Report numbers: E2B_05883463, E2B_05905647. ADRs for ABILIFY AND ARIPIPRAZOLE. Report numbers: E2B_05891329, E2B_05970491. ADRs for ARIPIPRAZOLE. Report numbers: 001015905, E2B_05969558.

Organization: Health Canada

224 page(s)
May 2023

Req # A-2022-001490

Adverse Drug Reactions (ADRs) for PREVMYIS. Report numbers: 000731335, E2B_02849440, E2B_03009833, E2B_02754235. ADRs for PROQUAD. Report numbers: E2B_03276676, E2B_03269645, 000912797. ADRs for RECOMBIVAX HB. Report numbers: E2B_02198873, E2B_02198905. ADR for ROTATEQ. Report number: 000911561.

Organization: Health Canada

189 page(s)
May 2023
Date modified: